253 related articles for article (PubMed ID: 27983657)
1. Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?
Pul R; Osmanovic A; Schmalstieg H; Pielen A; Pars K; Schwenkenbecher P; Sühs KW; Yildiz Ö; Frank B; Stangel M; Skripuletz T
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983657
[TBL] [Abstract][Full Text] [Related]
2. Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
Schröder K; Finis D; Harmel J; Ringelstein M; Hartung HP; Geerling G; Aktas O; Guthoff R
Mult Scler Relat Disord; 2015 Sep; 4(5):406-408. PubMed ID: 26346788
[TBL] [Abstract][Full Text] [Related]
3. Famous.
Kim MJ; Bhatti MT; Costello F
Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Thoo S; Cugati S; Lee A; Chen C
Mult Scler; 2015 Feb; 21(2):249-51. PubMed ID: 24696055
[TBL] [Abstract][Full Text] [Related]
5. Fingolimod-associated macular edema: A case report of late onset.
Karakosta C; Kourentis C
Eur J Ophthalmol; 2022 Jul; 32(4):NP56-NP60. PubMed ID: 33645300
[TBL] [Abstract][Full Text] [Related]
6. Real-world incidence of fingolimod-associated macular oedema.
Goh LY; Kirthi V; Silber E; Harvey JP; Jackson TL
Mult Scler Relat Disord; 2020 Jul; 42():102125. PubMed ID: 32403070
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Zarbin MA; Jampol LM; Jager RD; Reder AT; Francis G; Collins W; Tang D; Zhang X
Ophthalmology; 2013 Jul; 120(7):1432-9. PubMed ID: 23531349
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
Fruschelli M; Capozzoli M; Gelmi MC; Masi G; Annunziata P
Int Ophthalmol; 2019 Apr; 39(4):777-781. PubMed ID: 29500696
[TBL] [Abstract][Full Text] [Related]
9. Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Ueda N; Saida K
BMC Ophthalmol; 2015 Oct; 15():135. PubMed ID: 26481728
[TBL] [Abstract][Full Text] [Related]
10. [Early onset of fingolimod-associated macular edema].
Schelenz D; Kleiter I; Schöllhammer J; Rehrmann J; Elling M; Dick HB; Kakkassery V
Ophthalmologe; 2018 May; 115(5):424-428. PubMed ID: 28653209
[TBL] [Abstract][Full Text] [Related]
11. Fingolimod-associated macular edema: incidence, detection, and management.
Jain N; Bhatti MT
Neurology; 2012 Feb; 78(9):672-80. PubMed ID: 22371414
[TBL] [Abstract][Full Text] [Related]
12. Early and recurrent macular oedema in a patient treated with fingolimod.
Cifuentes-Canorea P; Nieves-Moreno M; Sáenz-Francés F; Santos-Bueso E
Neurologia (Engl Ed); 2019 Apr; 34(3):206-207. PubMed ID: 27776961
[No Abstract] [Full Text] [Related]
13. Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.
Akiyama H; Suzuki Y; Hara D; Shinohara K; Ogura H; Akamatsu M; Hasegawa Y
Medicine (Baltimore); 2016 Jul; 95(29):e4180. PubMed ID: 27442641
[TBL] [Abstract][Full Text] [Related]
14. Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod.
Nørgaard TL; Andersen CU; Hilt C; Andersen CU
Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):492-497. PubMed ID: 31880065
[TBL] [Abstract][Full Text] [Related]
15. Does fingolimod in multiple sclerosis patients cause macular edema?
Turaka K; Bryan JS
J Neurol; 2012 Feb; 259(2):386-8. PubMed ID: 22231867
[TBL] [Abstract][Full Text] [Related]
16. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
[No Abstract] [Full Text] [Related]
17. Fingolimod-associated macular oedema.
Jasani KM; Sharaf N; Rog D; Aslam T
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28619738
[No Abstract] [Full Text] [Related]
18. Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Laroni A; Brogi D; Brescia Morra V; Guidi L; Pozzilli C; Comi G; Lugaresi A; Turrini R; Raimondi D; Uccelli A; Mancardi GL
Neurol Sci; 2017 Jan; 38(1):53-59. PubMed ID: 27757552
[TBL] [Abstract][Full Text] [Related]
19. Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema.
Foos WF; Culp C; Asahi M; Patronas M
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36368737
[TBL] [Abstract][Full Text] [Related]
20. Postoperative cystoid macular oedema in a patient on fingolimod.
Gaskin JC; Coote M
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25969500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
